Carl Zeiss Meditec (OTCMKTS:CZMWY) Shares Gap Down on Analyst Downgrade

Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report)’s share price gapped down before the market opened on Wednesday after Barclays downgraded the stock from a hold rating to a strong sell rating. The stock had previously closed at $38.10, but opened at $35.47. Carl Zeiss Meditec shares last traded at $35.48, with a volume of 4,922 shares.

A number of other research firms have also recently weighed in on CZMWY. Morgan Stanley began coverage on Carl Zeiss Meditec in a report on Wednesday, September 2nd. They set an “underweight” rating for the company. UBS Group lowered Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a research note on Tuesday, August 11th. Zacks Research upgraded Carl Zeiss Meditec from a “strong sell” rating to a “hold” rating in a report on Tuesday, October 6th. Finally, The Goldman Sachs Group lowered Carl Zeiss Meditec from a “hold” rating to a “sell” rating in a research note on Monday, October 5th. Two investment analysts have rated the stock with a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Strong Sell”.

View Our Latest Research Report on Carl Zeiss Meditec

Carl Zeiss Meditec Stock Performance

The business has a fifty day moving average of $36.75 and a two-hundred day moving average of $33.01.

About Carl Zeiss Meditec

(Get Free Report)

Carl Zeiss Meditec AG is a medical technology company headquartered in Jena, Germany, and part of the ZEISS Group. The company develops, manufactures and distributes equipment and solutions for ophthalmology and microsurgery, serving hospitals, clinics and medical professionals worldwide. Its ophthalmic portfolio includes diagnostic systems for examining the eye, equipment for cataract and refractive surgery, surgical lasers, intraocular lenses and other related products. The company also supplies surgical microscopes, visualization systems and digital technologies used in neurosurgery, spine surgery, ear, nose and throat procedures, and other microsurgical specialties.

Read More

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.